Table 1.

Genetic status and p53-MCL rate of LCLs from familial breast and ovarian cancer

	BRCA1	BRCA2	CHK2	PALB2	ATM	p53-MCL%
BR36	wt	mut	nt	nt	nt	80
BR13	wt	mut	nt	nt	nt	76
BR409-3	mut	wt	nt	nt	nt	97
BR324-1	mut	wt	nt	nt	nt	85
BR404-1	mut	wt	wt	wt	wt	76
BR317	mut	wt	nt	nt	mut	50
BR377	wt	wt	wt	wt	mut	50
BR60-1	wt	wt	wt	wt	wt	71
BR107-1	wt	wt	wt	wt	wt	90
BR362-1	wt	wt	wt	wt	wt	92
BR494	wt	wt	wt	wt	wt	86
BR38	wt	wt	wt	wt	wt	91
BR48	wt	wt	wt	wt	wt	70
BR278-1	wt	wt	wt	wt	wt	80
BR501	wt	wt	mut	wt	wt	80

wt wild type, mut mutated, nt not tested